Abstract
Nosebleeds happen to most people at least once in their lives; however, people with risk factors are more predisposed. The method of treatment depends on the location and severity of bleeding, although in most cases, patients can manage it on their own. In general, literature supporting various treatments comes from heterogeneous patient populations and is generally of poor quality. Community-based approaches should always begin with general measures, including manual nostril compression with the possible use of topical vasoconstrictors and/or tranexamic acid. If medical attention is required, more invasive measures such as nasal packing, cauterization, or surgical approaches may be considered. In patients taking antithrombotic drugs with active epistaxis, the severity of bleeding, the status of anticoagulant therapy or platelet inhibition, and the overall risk of thrombosis should be evaluated to determine whether modification of therapy and consultation with the attending physician is warranted. Finally, in patients with recurrent epistaxis, preventive measures should be taken to ensure adequate hydration and avoid injury to the nasal passages. Field pharmacists working on the front lines are well positioned to identify patients suitable for self-management of nosebleeds and provide them with appropriate education and tools to manage and prevent future episodes. preventive measures should be taken to ensure adequate hydration and avoid injury to the nasal passages. Field pharmacists working on the front lines are well positioned to identify patients suitable for self-management of nosebleeds and provide them with appropriate education and tools to manage and prevent future episodes. preventive measures should be taken to ensure adequate hydration and avoid injury to the nasal passages. Field pharmacists working on the front lines are well positioned to identify patients suitable for self-management of nosebleeds and provide them with appropriate education and tools to manage and prevent future episodes.